Author Index Vol. 25, 2007
Okio Hino(Juntendo University), Ronnie T.P. Poon(Queen Mary Hospital), Yasuhiko Sugawara, Hyo‐Suk Lee(Seoul National University), Choon Hyuck David Kwon(Cleveland Clinic), Masatoshi Makuuchi(Nagano Children's Hospital), Kohei Ogawa(National Center For Child Health and Development), Chie Tatsumi(Kindai University), Shin Hwang, Hironori Haga(Kyoto University), Masatoshi Kudo(Kindai University), Satoshi Kitai(Kindai University), Kyung‐Suk Suh(Seoul National University Hospital), Shunsuke Takahashi(Kanagawa Dental University), Fumitaka Oike, Yoji Maetani, Doo Jin Kim, Jae‐Won Joh(Samsung Medical Center), Hobyung Chung(Kindai University), Hae Won Lee, Nam‐Joon Yi, Gyu‐Seong Choi, Sung Joo Kim(Hallym University), Hiroto Egawa(Kyoto University), Suk‐Koo Lee(Samsung Medical Center), Miki Nagashima, Toyokazu Fukunaga, Shinji Üemoto(Shiga University of Medical Science), Yasuhiro Ogura, Kazuomi Ueshima(Kindai University), Young Seok Han, Jae Berm Park(Samsung Medical Center), Takashi Itô(National Astronomical Observatory of Japan), Yasutsugu Takada(Kyoto University), Tatsuo Inoue, Sung‐Gyu Lee(Ulsan College), Woo Young Shin, Mikiko Ueda, Sumihito Tamura(Osaka Medical Center for Cancer and Cardiovascular Diseases), Seiji Haji(Kindai University), Kuhn Uk Lee(Seoul National University Hospital), Deok-Bog Moon, E.K. Cho, Yasunori Minami, Seisuke Sakamoto
Cited by 0
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k